Free Trial

Rapport Therapeutics 8/8/2024 Earnings Report

Rapport Therapeutics logo
$12.68 -0.32 (-2.46%)
As of 02/21/2025 04:00 PM Eastern

Rapport Therapeutics EPS Results

Actual EPS
-$1.70
Consensus EPS
-$0.68
Beat/Miss
Missed by -$1.02
One Year Ago EPS
N/A

Rapport Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Rapport Therapeutics Announcement Details

Quarter
Time
Before Market Opens

Conference Call Resources

Rapport Therapeutics Earnings Headlines

Rapport Therapeutics, Inc. (RAPP)
Rapport Therapeutics, Inc. (RAPP) Receives a Buy from Stifel Nicolaus
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."
If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.
See More Rapport Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Rapport Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rapport Therapeutics and other key companies, straight to your email.

About Rapport Therapeutics

Rapport Therapeutics (NASDAQ:RAPP) Inc. is a clinical-stage biotechnology company. It focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. Rapport Therapeutics Inc. is based in BOSTON.

View Rapport Therapeutics Profile

More Earnings Resources from MarketBeat